chevron_leftBack
As of 24 April 2025, Bio-Gate AG has a market cap of $8.57M USD, ranking #33727 globally and #387 in Germany. It ranks #3366 in the Healthcare sector, and #230 in the Medical Instruments & Supplies industry.
Key Stats
Market Cap
$8.57MUSD
7.53M EUR
Enterprise Value
$8.07MUSD
7.12M EUR
Revenue (TTM)
$8.66MUSD
7.61M EUR
EBITDA (TTM)
-$1.95MUSD
-1.72M EUR
Net Income (TTM)
-$2.28MUSD
-2.0M EUR
EBITDA Margin
-23%
Profit Margin
-26%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Marc Lloret-Grau
open_in_new
Employees
42
Founded
2005
Website
bio-gate.de
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 0% | 16% | 11% | 41% | -14% |
Upcoming Earnings
Earnings Date
Fri, May 2
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BIG1
Bio-Gate AG Akt. nach Kapitalherabsetzung
ISIN: DE000BGAG981
Shares Out.:
Shares Outstanding:
9.244M1
Shares Float:
1.063M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.8400 EUR | |
|
BIG1
Bio-Gate AG Akt. nach Kapitalherabsetzung
ISIN: DE000BGAG981
|
0.8400 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Bio-Gate AG
Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating, which protects the surfaces of medical implants against bacterial colonization. It also provides MicroSilver BG elemental microporous silver additives. The company’s products are used in large and medium-sized medical technology companies, pharmaceutical distributors, distribution companies, industrial companies, public sector companies, and hygiene-sensitive institutions. The company was incorporated in 2005 and is based in Nuremberg, Germany.
